Protein Synthesis and Post-Translational Modifications — MCQs
Techniques used for protein expression proteomics study include:
Apolipoprotein B-48 is made by which process?
Which of the following is a termination codon?
Which of the following is not associated with post-transcription modification?
miRNA binds to which part of the mRNA to inhibit translation?
Which of the following is the platinum-based chemotherapeutic agent used as first-line treatment for ovarian carcinoma?
What is the major site of protein glycosylation?
Which of the following drugs does not inhibit bacterial protein synthesis?
Which of the following is a function of ribozymes?
What is the term for a single mutation in a nucleotide base pair that results in a termination codon?
Protein Synthesis and Post-Translational Modifications Indian Medical PG Practice Questions and MCQs
Question 1: Techniques used for protein expression proteomics study include:
- A. PolyAcrylamide Gel Electrophoresis (PAGE)
- B. Gene Expression Analysis (indirectly related to proteomics)
- C. Mass Spectrometry
- D. All of the options (Correct Answer)
Explanation: ***All of the options*** - All listed techniques—**Polyacrylamide Gel Electrophoresis (PAGE)**, **Gene Expression Analysis**, and **Mass Spectrometry**—are used in protein expression proteomics studies, either directly or indirectly, to analyze and quantify proteins. - The integration of these various techniques provides a comprehensive approach to understanding protein expression profiles. *PolyAcrylamide Gel Electrophoresis (PAGE)* - **PAGE** (including 1D and 2D-PAGE) is a fundamental technique for separating proteins based on their **molecular weight** and **isoelectric point**, which is crucial for visualizing and quantifying expressed proteins. - It often serves as an initial separation step before more detailed analysis, such as **mass spectrometry**. *Gene Expression Analysis (indirectly related to proteomics)* - Although **gene expression analysis** (e.g., using **RT-PCR** or **microarrays**) measures mRNA levels, it is indirectly related to proteomics because mRNA levels often **correlate with protein levels**. - It provides insights into the **transcriptional regulation** that influences protein expression, complementing direct protein analysis. *Mass Spectrometry* - **Mass spectrometry** is a powerful and widely used technique in proteomics for **identifying, quantifying, and characterizing proteins** and peptides by measuring their **mass-to-charge ratio**. - It can be used for both **discovery proteomics** (identifying novel proteins) and **targeted proteomics** (quantifying specific proteins).
Question 2: Apolipoprotein B-48 is made by which process?
- A. DNA editing
- B. RNA editing (Correct Answer)
- C. RNA alternate splicing
- D. RNA interference
Explanation: ***RNA editing*** - Apolipoprotein B-48 is synthesized from ApoB-100 mRNA through a process called **RNA editing** (specifically ApoB mRNA editing) - This involves a **cytidine deaminase enzyme (APOBEC-1)** that converts cytidine to uridine at position 6666, changing a glutamine codon (CAA) to a premature stop codon (UAA) in the small intestine - This results in a truncated protein that is 48% the length of ApoB-100 - ApoB-48 is produced in the **intestine**, while ApoB-100 (unedited) is produced in the **liver** *DNA editing* - DNA editing refers to permanent modifications in the DNA sequence itself - The ApoB gene remains unchanged; only the mRNA transcript is edited in intestinal cells - This is not the mechanism for producing ApoB-48 *RNA alternate splicing* - Alternative splicing involves selecting different combinations of exons from pre-mRNA to produce multiple mRNA isoforms - This process creates different protein variants through exon inclusion/exclusion - ApoB-48 production does not involve alternative splicing but rather direct nucleotide modification (C to U) within the coding sequence *RNA interference* - RNA interference (RNAi) is a biological process involving small RNA molecules (siRNA, miRNA) that silence gene expression - RNAi typically degrades mRNA or blocks translation - This process is not involved in generating a truncated protein like ApoB-48 from the same mRNA transcript
Question 3: Which of the following is a termination codon?
- A. AUG
- B. UAA (Correct Answer)
- C. AUA
- D. AGG
Explanation: ***UAA*** - **UAA** is one of the three **stop codons** (UAA, UAG, UGA) that signals the termination of protein synthesis during translation. - When the ribosome encounters a UAA codon, no corresponding tRNA with an anticodon binds, and release factors bind instead, leading to the dissociation of the polypeptide chain. *AUG* - **AUG** is the universal **start codon** in most organisms, encoding for methionine in eukaryotes and N-formylmethionine in prokaryotes. - Its presence signals the initiation of protein synthesis, not its termination. *AUA* - **AUA** is a codon that codes for the amino acid **Isoleucine**. - It is a **sense codon** and does not act as a signal for termination. *AGG* - **AGG** is a codon that codes for the amino acid **Arginine**. - Similar to AUA, it is a **sense codon** and participates in elongating the polypeptide chain, rather than terminating it.
Question 4: Which of the following is not associated with post-transcription modification?
- A. 5' capping
- B. Glycosylation (Correct Answer)
- C. Methylation
- D. Endonuclease cleavage
Explanation: ***Glycosylation*** - **Glycosylation** is a type of post-translational modification, which involves the enzymatic addition of carbohydrates to proteins or lipids, not RNA. - This process is crucial for protein folding, stability, and function in the cell, occurring after translation has been completed. *5' capping* - **5' capping** is a crucial post-transcriptional modification of eukaryotic pre-mRNA, involving the addition of a 7-methylguanosine cap to the 5' end. - This cap protects the mRNA from degradation, facilitates nuclear export, and is essential for translation initiation. *Methylation* - **Methylation** can occur as a post-transcriptional modification, affecting various RNA types including tRNA, rRNA, and mRNA. - For mRNA, internal methylation, particularly of adenosine residues (m6A), plays a role in mRNA stability, splicing, and translation regulation. *Endonuclease cleavage* - **Endonuclease cleavage** is a significant post-transcriptional modification, particularly in the maturation of rRNA and tRNA, where larger precursor molecules are cut into functional smaller units. - In mRNA processing, endonuclease cleavage is involved in the formation of the 3' end, signaling for the addition of the poly-A tail.
Question 5: miRNA binds to which part of the mRNA to inhibit translation?
- A. Gene promoter
- B. 3'UTR (Correct Answer)
- C. Gene body
- D. 5'UTR
Explanation: ***3'UTR*** - MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate gene expression. - They primarily bind to the **3' untranslated region (3'UTR)** of messenger RNA (mRNA) molecules, leading to translational repression or mRNA degradation. *Gene promoter* - The **gene promoter** is a region of DNA located upstream of a gene, where regulatory proteins bind to initiate transcription. - miRNAs do not directly bind to gene promoters to inhibit translation. *Gene body* - The **gene body** refers to the entire transcribed region of a gene, including exons and introns. - While some regulatory elements can be found within the gene body, the primary binding site for miRNAs to exert translational control is the 3'UTR. *5'UTR* - The **5' untranslated region (5'UTR)** is located at the 5' end of an mRNA molecule, upstream of the start codon. - While the 5'UTR can play a role in regulating translation initiation, it is not the primary target for miRNA binding to inhibit translation.
Question 6: Which of the following is the platinum-based chemotherapeutic agent used as first-line treatment for ovarian carcinoma?
- A. Cyclophosphamide
- B. Methotrexate
- C. Cisplatin (Correct Answer)
- D. Dacarbazine
Explanation: ***Cisplatin*** - **Cisplatin** is a platinum-based chemotherapy drug that forms **DNA cross-links**, inhibiting DNA synthesis and leading to the death of rapidly dividing cells, making it highly effective against **ovarian carcinoma**. - It is a cornerstone of chemotherapy regimens for ovarian cancer, often used in combination with other agents such as paclitaxel. *Methotrexate* - **Methotrexate** is an **antimetabolite** that inhibits dihydrofolate reductase, thereby interfering with DNA synthesis. - While it is used in various cancers like leukemia, lymphoma, and some solid tumors (e.g., breast cancer, gestational trophoblastic disease), it is **not a primary recommended drug for ovarian carcinoma**. *Cyclophosphamide* - **Cyclophosphamide** is an **alkylating agent** that causes DNA damage, leading to cell death. - It is used in many cancers, including lymphoma, breast cancer, and some leukemias, but it is **not a first-line or primary agent for ovarian carcinoma** in contemporary treatment guidelines. *Dacarbazine* - **Dacarbazine** is an **alkylating agent** primarily used in the treatment of **malignant melanoma** and Hodgkin lymphoma. - It is **not indicated for the treatment of ovarian carcinoma**.
Question 7: What is the major site of protein glycosylation?
- A. Ribosome and Golgi body
- B. ER and Ribosome
- C. Ribosome and Cytoplasm
- D. ER and Golgi body (Correct Answer)
Explanation: ***ER and Golgi body*** - The **endoplasmic reticulum (ER)** is the primary site for **N-linked glycosylation**, where carbohydrates are added to the asparagine residues of nascent proteins. - The **Golgi apparatus** is crucial for further modification and processing of these N-linked glycans, as well as the site for **O-linked glycosylation**, where sugars are added to serine or threonine residues. *Ribosome and Golgi body* - **Ribosomes** are responsible for **protein synthesis (translation)** but do not directly perform glycosylation, which is a post-translational modification. - While the **Golgi body** is a site of glycosylation, the ribosome's inclusion makes this option incorrect as the ribosome's role precedes glycosylation. *ER and Ribosome* - The **ER** is a major site of protein glycosylation, especially N-linked glycosylation. - However, **ribosomes** are involved in protein synthesis and lack the enzymatic machinery for adding sugar moieties to proteins. *Ribosome and Cytoplasm* - **Ribosomes** synthesize proteins, but glycosylation does not occur there. - The **cytoplasm** is the site for many metabolic pathways, but major protein glycosylation events mostly occur within the ER and Golgi.
Question 8: Which of the following drugs does not inhibit bacterial protein synthesis?
- A. Aminoglycosides
- B. Chloramphenicol
- C. Clindamycin
- D. Sulfonamides (Correct Answer)
Explanation: ***Sulfonamides*** - Sulfonamides do **NOT** inhibit bacterial protein synthesis; instead, they inhibit **folic acid synthesis**. - They act as **competitive inhibitors** of dihydropteroate synthase, an enzyme involved in the synthesis of dihydrofolic acid. - Folic acid is essential for nucleotide synthesis and DNA replication, making sulfonamides bacteriostatic agents that work through a completely different mechanism than protein synthesis inhibitors. *Aminoglycosides* - Aminoglycosides bind to the **30S ribosomal subunit**, causing misreading of mRNA and premature termination of protein synthesis. - This leads to the production of **abnormal and non-functional proteins**, ultimately killing the bacterial cell. *Chloramphenicol* - Chloramphenicol binds to the **50S ribosomal subunit**, thereby inhibiting the peptidyl transferase enzyme. - This prevents the formation of **peptide bonds** between amino acids, effectively blocking protein elongation. *Clindamycin* - Clindamycin also binds to the **50S ribosomal subunit**, specifically at the P-site. - It interferes with the **translocation step** of protein synthesis, preventing ribosomal movement along the mRNA.
Question 9: Which of the following is a function of ribozymes?
- A. Peptidyl transferase activity (Correct Answer)
- B. Cut DNA at specific site
- C. GTPase activity
- D. Participate in DNA synthesis
Explanation: ***Peptidyl transferase activity*** - The **ribosome's large subunit**, which contains **ribosomal RNA (rRNA)**, catalyzes the formation of peptide bonds during protein synthesis. - This **rRNA enzyme**, known as a **ribozyme**, exhibits **peptidyl transferase activity**. *Cut DNA at specific site* - This function is primarily carried out by **restriction enzymes**, which are **proteins**, not ribozymes. - **Ribozymes** are **RNA molecules** with catalytic activity and do not typically cleave DNA. *Participate in DNA synthesis* - **DNA synthesis** is mediated by **DNA polymerases** and other **protein enzymes**, not ribozymes. - Ribozymes' primary roles involve **RNA processing** and **peptide bond formation**. *GTPase activity* - **GTPase activity** is characteristic of **G-proteins**, which are **protein enzymes** involved in signal transduction and cell regulation. - While some ribosomal activities are **GTP-dependent**, the **GTPase itself is a protein**, not the ribozyme component.
Question 10: What is the term for a single mutation in a nucleotide base pair that results in a termination codon?
- A. Missense mutation
- B. Nonsense mutation (Correct Answer)
- C. Termination mutation
- D. Silent mutation
Explanation: ***Nonsense mutation*** - A **nonsense mutation** occurs when a single nucleotide base pair change leads to the formation of a **premature stop codon**, which results in a truncated and often non-functional protein. - The term "nonsense" refers to the fact that the new codon signals an early termination of protein synthesis. *Missense mutation* - A **missense mutation** involves a single nucleotide change that results in a codon coding for a **different amino acid**, potentially altering protein function but not necessarily terminating it. - This type of mutation can have varying effects on protein function, from benign to severe, depending on the amino acid substitution. *Termination mutation* - While a nonsense mutation does result in **premature termination**, "termination mutation" is not the standard or most precise scientific term used to describe this specific type of genetic alteration. - The more accurate and widely accepted terminology is **nonsense mutation** for a change leading to a stop codon. *Silent mutation* - A **silent mutation** is a type of point mutation that changes a single nucleotide, but does not change the amino acid sequence of the protein due to the **degeneracy of the genetic code**. - These mutations have **no observable effect** on the organism's phenotype as the protein produced remains unchanged.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free